Dishman Carbogen Amcis Ltd.
BSE: 540701 | Sector: Health care |
NSE: DCAL | ISIN Code: INE385W01011 |
BSE 00:00 | 06 Jul | 117.25 |
-0.70 (-0.59%) |
OPEN
115.30 |
HIGH
119.85 |
LOW
115.30 |
NSE 00:00 | 06 Jul | 117.20 |
-0.85 (-0.72%) |
OPEN
118.75 |
HIGH
120.40 |
LOW
116.50 |
OPEN | 115.30 |
PREVIOUS CLOSE | 117.95 |
VOLUME | 24953 |
52-Week high | 259.50 |
52-Week low | 97.55 |
P/E | |
Mkt Cap.(Rs cr) | 1,838 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Dishman Carbogen Amcis Ltd. (DCAL) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Aurobindo Pharma | 543.80 | 10.50 | 1.97 | 3112.91 |
Cipla | 945.85 | 8.15 | 0.87 | 2468.28 |
Dr Reddy's Labs | 4393.80 | 4.35 | 0.10 | 2186.40 |
Sun Pharma.Inds. | 837.70 | 2.15 | 0.26 | 2139.70 |
Divi's Lab. | 3646.40 | 36.05 | 1.00 | 1954.72 |
Glaxosmi. Pharma | 1545.10 | 3.70 | 0.24 | 1690.53 |
Alkem Lab | 3081.75 | 31.35 | 1.03 | 1685.08 |
Glenmark Pharma. | 388.90 | 7.60 | 1.99 | 1649.45 |
Zydus Lifesci. | 365.95 | 4.60 | 1.27 | 1476.20 |
Lupin | 630.10 | 2.70 | 0.43 | 1258.62 |
Alembic Pharma | 728.85 | 6.00 | 0.83 | 1175.39 |
Ipca Labs. | 944.00 | 16.10 | 1.74 | 1140.77 |
Gland Pharma | 2574.55 | 44.55 | 1.76 | 997.01 |
Torrent Pharma. | 2898.85 | 7.00 | 0.24 | 991.45 |
Sanofi India | 6485.80 | 42.15 | 0.65 | 944.40 |
Laurus Labs | 468.80 | 5.50 | 1.19 | 750.09 |
Abbott India | 19189.85 | 559.05 | 3.00 | 690.69 |
Ajanta Pharma | 1190.95 | -28.65 | -2.35 | 675.64 |
Wockhardt | 206.10 | 0.40 | 0.19 | 593.29 |
Granules India | 275.25 | -2.10 | -0.76 | 552.78 |
Quick Links for Dishman Carbogen Amcis:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices